A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome.

J Neurodev Disord · 2017 · PMC5540519 · PMID 28764646

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

a positive trendp = 0.08so close (0.05 < p ≤ 0.1)

4.2 ± 0.31, p = 0.02) as well as a positive trend in attention (4.7 ± 0.32 vs. 4.0 ± 0.30, p = 0.08).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.